This web publication constitutes a notice for the purposes of regulations 42ZCZS and 42ZCZX of the Therapeutic Goods Regulations 1990 (the Regulations). In accordance with regulations 42ZCZS and 42ZCZX, this notice publishes the:
A decision made by a delegate of the Secretary pursuant to regulations 42ZCZR and 42ZCZU;
reasons for that final decision; and
date of effect of the decision.
Final decision in relation to paracetamol - correction
The amendments to the Schedule 2 entry for paracetamol that were depicted in the final decision notice incorrectly showed under clause g) iii) (A) the retention of the existing wording ‘or in a container with a child-resistant closure’. However, as reflected in the reasons, the correct decision is that these words are to be removed, to require tablet and capsule preparations on general sale to be in blister packaging. From 1 February 2025, the Poisons Standard will be amended so that general sale and Schedule 2 paracetamol tablets and capsules will be required to be in blister packaging.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.